Larvol Delta - CytoImmune-to-Present-New-Preclinical-Data-Highlighting-Potential-of-Novel-TRACKNK-Cell-Therapies-as-Treatments-for-both-Solid-Tumors-and-Hematologic-Malignancies

CYTO-102 - CytoImmune

CYTO NK-201 - CytoImmune

https://www.businesswire.com/news/home/20220308006249/en/CytoImmune-to-Present-New-Preclinical-Data-Highlighting-Potential-of-Novel-TRACK-NK-Cell-Therapies-as-Treatments-for-both-Solid-Tumors-and-Hematologic-Malignancies/

Mar 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev